Loughlan Weatherly

Emyria (ASX:EMD)

How do you fast-track clinical research and optimise the efficacy of novel treatments and therapies? How do you demystify even the most complex diseases and provide more effective, completely individualised care? How do you help people everywhere live happpier, healthier lives? At Emyria, we're doing it by developing technology-powered health services that elevate clinical care and deliver deeper clinical insights. By learning from every patient. By testing and validating novel treatments in the real world. In real time. By diving deeper into each patient's case, especially patients who have run out of options. By collecting live, dynamic, multidimensional patient data and generating regulator-grade clinical evidence. By pioneering new methodologies and technologies to standardise and systematise that data and evidence. By making patients part of the clinical research journey and clinical innovation part of every patient's health journey. This is what we call evidence-generating care. Ours is a collaborative vision and venture. We're bringing together people and partners from all over the world for the greater good. Clinicians, patients, researchers and innovators, all advancing medical knowledge and science to transform health outcomes for patients and benefit humanity. We're caring, curious and courageous. And we're passionate about thinking more deeply and innovatively about helping people thrive, no matter what medical challenges they face. So, have we perfected every treatment? Can we cure every disease and remedy every condition? Are we able to help everyone live longer, healthier, happier lives? We don't have all the answers. Yet. But together, we'll find them.